BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schütz SG, Dunn A, Braley TJ, Pitt B, Shelgikar AV. New frontiers in pharmacologic obstructive sleep apnea treatment: A narrative review. Sleep Med Rev 2021;57:101473. [PMID: 33853035 DOI: 10.1016/j.smrv.2021.101473] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 McNicholas WT, Pevernagie D. Obstructive sleep apnea: transition from pathophysiology to an integrative disease model. J Sleep Res 2022;:e13616. [PMID: 35609941 DOI: 10.1111/jsr.13616] [Reference Citation Analysis]
2 Ip MSM, Chung KF. Pharmacotherapy for obstructive sleep apnoea: Is the magic bullet in sight? Respirology 2021;26:835-6. [PMID: 34346131 DOI: 10.1111/resp.14128] [Reference Citation Analysis]
3 Arzt M. Schlafbezogene Atmungsstörungen – Update 2021. Somnologie. [DOI: 10.1007/s11818-022-00344-w] [Reference Citation Analysis]
4 Zha S, Yang H, Yue F, Zhang Q, Hu K. Combined noradrenergic plus antimuscarinic agents for obstructive sleep apnea - A systematic review and meta-analysis of randomized controlled trials. Sleep Medicine Reviews 2022. [DOI: 10.1016/j.smrv.2022.101649] [Reference Citation Analysis]